Silver Book Fact

Resonable disease prevention and management efforts could add $5.7 trillion to the nation’s economic output by 2050– a boost of 18%.

Milken Institute. The Economic Burden of Chronic Disease on the United States; http://www.chronicdiseaseimpact.com/state_sheet/USA.pdf

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Medicines in Development for Older Americans  
  • Spending $11,000 on general medical care adds an average of 1 year of life. Spending only $1,345 on pharmaceutical research and development yields the same return.  
  • Private health insurance benefit spending is predicted to slow from a peak of 9.5% in 2001 to 4.7% in 2006, partially because of Medicare Part D.  
  • If resonable improvements in preventing and managing chronic disease are made, 40.2 million cases of chronic disease will be avoided in 2023.  
  • For each $1 spent on newer pharmaceuticals. $6.17 is saved in total health care spending. $4.44 of this savings is in hospital spending alone.